New mutations inactivating transferrin receptor 2 in hemochromatosis type 3.

Hereditary hemochromatosis usually results from C282Y homozygosity in the HFE gene on chromosome 6p. Recently, a new type of hemochromatosis (HFE3) has been characterized in 2 unrelated Italian families with a disorder linked to 7q. Patients with HFE3 have transferrin receptor 2 (TFR2) inactivated by a homozygous nonsense mutation (Y250X). Here the identification of 2 new TFR2 mutations is reported. In a large inbred family from Campania, a frameshift mutation (84-88 insC) in exon 2 that causes a premature stop codon (E60X) is identified. In a single patient with nonfamilial hemochromatosis, a T-->A transversion (T515A), which causes a Methionine-->Lysine substitution at position 172 of the protein (M172K), has been characterized. TFR2 gene gives origin to 2 alternatively spliced transcripts-the alpha-transcript, which may encode a transmembrane protein, and the beta-transcript, a shorter, possibly intracellular variant. Based on their positions, the effects of the identified mutations on the 2 TFR2 forms are expected to differ. Y250X inactivates both transcripts, whereas E60X inactivates only the alpha-form. M172K has a complex effect: it causes a missense in the alpha-form, but it may also prevent the beta-form production because it affects its putative initiation codon. Analysis of the clinical phenotype of 13 HFE3 homozygotes characterized at the molecular level has shown a variable severity, from nonexpressing patients to severe clinical complications. The identification of new mutations of TFR2 confirms that this gene is associated with iron overload and offers a tool for molecular diagnosis in patients without HFE mutations.

[1]  N. Andrews,et al.  Comparison of the Interactions of Transferrin Receptor and Transferrin Receptor 2 with Transferrin and the Hereditary Hemochromatosis Protein HFE* , 2000, The Journal of Biological Chemistry.

[2]  D. Girelli,et al.  Haemochromatosis in patients with β‐thalassaemia trait , 2000, British journal of haematology.

[3]  W. Griffiths,et al.  Haemochromatosis: novel gene discovery and the molecular pathophysiology of iron metabolism. , 2000, Human molecular genetics.

[4]  G. Mancia,et al.  Two novel nonsense mutations of HFE gene in five unrelated italian patients with hemochromatosis. , 2000, Gastroenterology.

[5]  Paolo Gasparini,et al.  The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22 , 2000, Nature Genetics.

[6]  N. Andrews,et al.  Genes that modify the hemochromatosis phenotype in mice. , 2000, The Journal of clinical investigation.

[7]  W. Sly,et al.  Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. Bjorkman,et al.  Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor , 2000, Nature.

[9]  H. Koeffler,et al.  Molecular Cloning of Transferrin Receptor 2 , 1999, The Journal of Biological Chemistry.

[10]  J. Dooley,et al.  A novel mutation of HFE explains the classical phenotype of genetic hemochromatosis in a C282Y heterozygote. , 1999, Gastroenterology.

[11]  J. Barton,et al.  Two novel missense mutations of the HFE gene (I105T and G93R) and identification of the S65C mutation in Alabama hemochromatosis probands. , 1999, Blood cells, molecules & diseases.

[12]  M. Cazzola,et al.  Juvenile hemochromatosis locus maps to chromosome 1q. , 1999, American journal of human genetics.

[13]  C. Camaschella,et al.  Inherited HFE‐unrelated hemochromatosis in italian families , 1999, Hepatology.

[14]  J. L. Le Gall,et al.  Phenotypic expression of HFE mutations: a French study of 1110 unrelated iron-overloaded patients and relatives. , 1999, Gastroenterology.

[15]  H. Dietz,et al.  Nonsense-mediated mRNA decay in health and disease. , 1999, Human molecular genetics.

[16]  J. Crowe,et al.  Hemochromatosis in Ireland and HFE. , 1998, Blood cells, molecules & diseases.

[17]  B. Bacon,et al.  Clinical characteristics of hereditary hemochromatosis patients who lack the C282Y mutation , 1998 .

[18]  D. Girelli,et al.  Heterogeneity of hemochromatosis in Italy. , 1998, Gastroenterology.

[19]  P. Bjorkman,et al.  Crystal Structure of the Hemochromatosis Protein HFE and Characterization of Its Interaction with Transferrin Receptor , 1998, Cell.

[20]  J. Castilla,et al.  Lack of benefit of protease inhibitors on HCV viremia in HIV-infected patients. , 1998, Journal of hepatology.

[21]  Esin,et al.  HFE mutations in patients with hereditary haemochromatosis in Sweden , 1998, Journal of internal medicine.

[22]  S. Chakrabarti,et al.  Genotypic/phenotypic correlations in genetic hemochromatosis: evolution of diagnostic criteria. , 1998, Gastroenterology.

[23]  L. Powell.  Hereditary diseases of the liver , 1998 .

[24]  C. Camaschella.  Juvenile haemochromatosis. , 1998, Bailliere's clinical gastroenterology.

[25]  Roger Williams,et al.  A simple genetic test identifies 90% of UK patients with haemochromatosis , 1997, Gut.

[26]  D. Girelli,et al.  Juvenile and Adult Hemochromatosis Are Distinct Genetic Disorders , 1997, European journal of human genetics : EJHG.

[27]  P. Brissot,et al.  Clinical Features of Genetic Hemochromatosis in Women Compared with Men , 1997, Annals of Internal Medicine.

[28]  D. Girelli,et al.  Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. , 1997, American journal of human genetics.

[29]  J. Vinel,et al.  Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients , 1997, Immunogenetics.

[30]  C. Venditti,et al.  Mutation analysis in hereditary hemochromatosis. , 1996, Blood cells, molecules & diseases.

[31]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[32]  P. Gasparini,et al.  Development of RNA‐SSCP protocols for the identification and screening of CFTR mutations: Identification of two new mutations , 1994, Human mutation.

[33]  G. Sarkar,et al.  Screening for mutations by RNA single-strand conformation polymorphism (rSSCP): comparison with DNA-SSCP. , 1992, Nucleic acids research.

[34]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .